David A. Buckel's Net Worth
-$14.5 Thousand
Who is David A. Buckel?
David A. Buckel does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include SMTP, Inc., and Scopus BioPharma Inc..
SEC CIK
David A. Buckel's CIK is 0001597303
Past Insider Trading and Trends
2016 was David A. Buckel's most active year for acquiring shares with 5 total transactions. David A. Buckel's most active month to acquire stocks was the month of December. 2021 was David A. Buckel's most active year for disposing of shares, totalling 2 transactions. David A. Buckel's most active month to dispose stocks was the month of August. 2019 saw David A. Buckel paying a total of $12,800.00 for 2,904 shares, this is the most they've acquired in one year. In 2021 David A. Buckel cashed out on 44,237 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SMTP, Inc. No price found
InvestorDavid A. Buckel used to own units in Common Stock but no longer holds any shares there.acquired a total of 27,749 shares in SMTP, Inc. at a cost of $14,540.00, David also disposed a total of 28,725 shares of SMTP, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -28.24K |
—
|
—
|
0
|
Sep 1
| |||
Form 4
| +1.69% | 469 |
—
|
—
| 28.24K |
Jul 21
| |||
Form 4
| +1.68% | 459 |
—
|
—
| 27.77K |
Apr 28
| |||
Form 4
| +1.66% | 446 |
—
|
—
| 27.31K |
Jan 28
| |||
Form 4
| +2.71% | 708 |
—
|
—
| 26.86K |
Oct 20
| |||
Form 4
| +3.54% | 895 |
—
|
—
| 26.16K |
Aug 10
| |||
Form 4
| +5.01% | 1.21K |
—
|
—
| 25.26K |
May 19
| |||
Form 4
| +2.87% | 670 |
—
|
—
| 24.05K |
Jan 21
| |||
Form 4
| +3.17% | 718 |
—
|
—
| 23.38K |
Oct 21
| |||
Form 4
| +2.65% | 585 |
—
|
—
| 22.67K |
Jul 24
| |||
Form 4
| +4.74% | 1K |
$12.80 | $12,800.00 | 22.08K |
Apr 23
| |||
Form 4
| -2.26% | -488.00 |
—
|
—
| 21.08K |
Apr 23
| |||
Form 4
| +3.01% | 601 |
—
|
—
| 20.59K |
Jan 21
| |||
Form 4
| +2.89% | 562 |
—
|
—
| 19.99K |
Oct 17
| |||
Form 4
| +4.65% | 864 |
—
|
—
| 19.43K |
Jul 20
| |||
Form 4
| +8.05% | 1.38K |
—
|
—
| 18.57K |
Apr 24
| |||
Form 4
| +11.64% | 1.79K |
—
|
—
| 17.18K |
Jan 19
| |||
Form 4
| +16.54% | 2.19K |
—
|
—
| 15.39K |
Oct 23
| |||
Form 4
| +14.50% | 1.67K |
—
|
—
| 13.21K |
Jul 28
| |||
Form 4
| +10.67% | 1.11K |
—
|
—
| 11.54K |
Apr 20
| |||
Form 4
| +9.99% | 947 |
—
|
—
| 10.42K |
Jan 20
| |||
Form 4
| +11.73% | 0.99K |
—
|
—
| 9.48K |
Oct 20
| |||
Form 4
| +14.16% | 1.05K |
—
|
—
| 8.48K |
Jul 20
| |||
Form 4
| +21.05% | 1.29K |
—
|
—
| 7.43K |
Apr 20
| |||
Form 4
| +10.84% | 600 |
$2.90 | $1,740.00 | 6.14K |
Feb 22
| |||
Form 4
| +37.70% | 1.52K |
—
|
—
| 5.54K |
Jan 20
| |||
Form 4
| +35.11% | 1.04K |
—
|
—
| 4.02K |
Oct 20
| |||
Form 4
| +41.65% | 875 |
—
|
—
| 2.98K |
Sep 9
| |||
Form 4
| +29.21% | 475 |
—
|
—
| 2.1K |
May 9
| |||
Form 4
| +33.72% | 410 |
—
|
—
| 1.63K |
Jan 28
| |||
Form 4
| +49.20% | 401 |
—
|
—
| 1.22K |
Nov 4
| |||
Form 4
|
∞
| 815 |
—
|
—
| 815 |
Jun 9 - Aug 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Scopus BioPharma Inc. (SCPS) Snapshot price: $0.0003
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||